168 related articles for article (PubMed ID: 15780875)
1. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
[TBL] [Abstract][Full Text] [Related]
2. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
[TBL] [Abstract][Full Text] [Related]
3. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
Kuhöber A; Pudollek HP; Reifenberg K; Chisari FV; Schlicht HJ; Reimann J; Schirmbeck R
J Immunol; 1996 May; 156(10):3687-95. PubMed ID: 8621903
[TBL] [Abstract][Full Text] [Related]
4. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
5. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
[TBL] [Abstract][Full Text] [Related]
6. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.
Le Borgne S; Mancini M; Le Grand R; Schleef M; Dormont D; Tiollais P; Rivière Y; Michel ML
Virology; 1998 Jan; 240(2):304-15. PubMed ID: 9454704
[TBL] [Abstract][Full Text] [Related]
7. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.
Mancini M; Hadchouel M; Tiollais P; Michel ML
J Immunol; 1998 Nov; 161(10):5564-70. PubMed ID: 9820533
[TBL] [Abstract][Full Text] [Related]
8. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.
Livingston BD; Crimi C; Grey H; Ishioka G; Chisari FV; Fikes J; Grey H; Chesnut RW; Sette A
J Immunol; 1997 Aug; 159(3):1383-92. PubMed ID: 9233635
[TBL] [Abstract][Full Text] [Related]
9. [Specific immune responses in H-2d mice after DNA immunization of HBV core gene].
Huang Z; Lu S; Liu N
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):107-9. PubMed ID: 10488422
[TBL] [Abstract][Full Text] [Related]
10. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
[TBL] [Abstract][Full Text] [Related]
11. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.
Livingston BD; Alexander J; Crimi C; Oseroff C; Celis E; Daly K; Guidotti LG; Chisari FV; Fikes J; Chesnut RW; Sette A
J Immunol; 1999 Mar; 162(5):3088-95. PubMed ID: 10072562
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group.
Heathcote J; McHutchison J; Lee S; Tong M; Benner K; Minuk G; Wright T; Fikes J; Livingston B; Sette A; Chestnut R
Hepatology; 1999 Aug; 30(2):531-6. PubMed ID: 10421664
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
[TBL] [Abstract][Full Text] [Related]
14. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
Schirmbeck R; Reimann J
Biol Chem; 2001 Apr; 382(4):543-52. PubMed ID: 11405219
[TBL] [Abstract][Full Text] [Related]
15. Targeting dendritic cells to enhance DNA vaccine potency.
You Z; Huang X; Hester J; Toh HC; Chen SY
Cancer Res; 2001 May; 61(9):3704-11. PubMed ID: 11325842
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance.
Vitiello A; Sette A; Yuan L; Farness P; Southwood S; Sidney J; Chesnut RW; Grey HM; Livingston B
Eur J Immunol; 1997 Mar; 27(3):671-8. PubMed ID: 9079808
[TBL] [Abstract][Full Text] [Related]
17. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T
Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
19. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes.
Ciernik IF; Berzofsky JA; Carbone DP
J Immunol; 1996 Apr; 156(7):2369-75. PubMed ID: 8786293
[TBL] [Abstract][Full Text] [Related]
20. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.
Loirat D; Lemonnier FA; Michel ML
J Immunol; 2000 Oct; 165(8):4748-55. PubMed ID: 11035120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
